Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain compliance ...
Pharmaceutical companies face growing debt costs, expiring patents, protracted development cycles and industry disruption. Fresh consideration of investment could reignite growth As 2025 approaches, ...
Bendell said, “I am honored and committed to fostering a culture of collaborative innovation as we look to gain increased traction in the U.S. market. Gelteq’s ingestible gel technology has the ...
Scientists are repurposing their research about bacteria-powered biobatteries into a new idea for artificial plants that can feed off carbon dioxide, give off oxygen and even generate a little power.
Gelteq Limited ("Gelteq" or the "Company"), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible ...
The Benchmark Company, LLC acted as the lead managing underwriter for the offering. The Company has granted the underwriter a 45-day option to purchase up to an additional 195,000 ordinary shares ...